Accumulating evidence points toward a very high prevalence of prolonged neurological
symptoms among coronavirus disease 2019 (COVID-19) survivors. To date, there are no …

The coronavirus disease (COVID-19), caused by severe acute respiratory syndrome-
coronavirus-2 (SARS-CoV-2) infection, is leading to unknown and unusual health conditions …

Purpose To find out what is known from literature about Long COVID until January 30, 2021.
Methods We undertook a four-step search with no language restriction. A preliminary search …

COVID-19, which is caused by the SARS-CoV-2, has ravaged the world for the past 2 years.
Here, we review the current state of research into the disease with focus on its history …

An estimated 10–15% of those infected with SARS-CoV-2 may have post-COVID-19
condition. Common lingering signs and symptoms include shortness of breath, fatigue, high …

Objectives To investigate superiority of a telerehabilitation programme for COVID-19
(TERECO) over no rehabilitation with regard to exercise capacity, lower limb muscle …

Patients diagnosed with coronavirus disease 2019 (COVID-19) associated with severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection frequently experience …

Background The long-term effects of SARS-CoV-2 infection on pulmonary structure and
function remain incompletely characterized. Purpose To test whether SARS-CoV-2 infection …

As of January 2022, at least 60 million individuals are estimated to develop post-acute
sequelae of SARS-CoV-2 (PASC) after infection with severe acute respiratory syndrome …

Knowledge on the sequelae of Coronavirus Disease 2019 (COVID-19) remains limited due
to the relatively recent onset of this pathology. However, the literature on other types of …